World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   1729 records for 482 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
RecruitingYesNCT03101215
Workload of Water Polo Players Following a Phosphorus Manipulated High Carbohydrate Meal
24/03/2017
RecruitingYesCTRI/2017/03/007979
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan (LixiRam)
01-03-2017
RecruitingYesNCT03079050
A Controlled Trial of Dexlansoprazole 30mg vs. Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan
27/02/2017
RecruitingNoNCT03060434
Pentoxifylline and Lumbar Radiculopathy
18/02/2017
AuthorisedYesEUCTR2016-001560-11-SK
Study of safety of QAW039 in patients (= 12 yrs) with asthma inadequately controlled on standard-of-care asthma therapy 12/01/2017
RecruitingNoNCT03004482
Analysis of Video Imaging in Newborns
20/12/2016
RecruitingYesNCT02984800
Effectiveness of Single Paravertebral Blockade Injection for Herniorrhaphy in Children
03/12/2016
RecruitingYesNCT02983591
Effect of Misoprostol in Reducing Post Partum Hemorrhage After Labor Induction by Oxytocin
30/11/2016
AuthorisedYesEUCTR2016-003467-19-GB
safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre / postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2016-003467-19-PTsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease14/12/2016
AuthorisedEUCTR2016-003467-19-ATsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease03/02/2017
AuthorisedEUCTR2016-003467-19-ESSafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease10/02/2017
AuthorisedEUCTR2016-003467-19-NLsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease23/11/2016
AuthorisedEUCTR2016-003467-19-HUsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease25/11/2016
AuthorisedEUCTR2016-003467-19-BGsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease07/12/2016
AuthorisedEUCTR2016-003467-19-GRsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease03/01/2017
07/11/2016
AuthorisedYesEUCTR2016-000989-35-SE
Efficacy and safety of semaglutide versus canagliflozin as add-on to metformin in subjects with type 2 diabetes
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2016-000989-35-GBEfficacy and safety of semaglutide versus canagliflozin as add-on to metformin in subjects with type 2 diabetes16/11/2016
28/10/2016
     
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history